Review Article

Valuing the Economic Costs of Allergic Rhinitis, Acute Bronchitis, and Asthma from Exposure to Indoor Dampness and Mold in the US

Table 1

Meta-analysis results for risk and attributable fractions of risks of selected diseases from indoor dampness and mold exposure.

ReferenceDiseaseDisease prevalenceRisk factorOR (95% CI)AF

Jaakkola et al. [8]Allergic rhinitis0.075Visible mold1.51 (1.39–1.64)0.15

Fisk et al. [9]Current asthma0.082Dampness &/or mold1.56 (1.30–1.86) 0.16

Fisk et al. [10]Acute bronchitis0.050Dampness &/or mold1.45 (1.31–1.59)0.14

CDC [14] and Worrall [15].